Annual Revenue
$398.20 M
+$184.00 M+85.90%
31 December 2023
Summary:
Catalyst Pharmaceuticals annual revenue is currently $398.20 million, with the most recent change of +$184.00 million (+85.90%) on 31 December 2023. During the last 3 years, it has risen by +$279.13 million (+234.42%). CPRX annual revenue is now at all-time high.CPRX Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Revenue
$128.69 M
+$5.99 M+4.88%
30 September 2024
Summary:
Catalyst Pharmaceuticals quarterly revenue is currently $128.69 million, with the most recent change of +$5.99 million (+4.88%) on 30 September 2024. Over the past year, it has increased by +$26.01 million (+25.33%). CPRX quarterly revenue is now at all-time high.CPRX Quarterly Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM Revenue
$460.48 M
+$26.01 M+5.99%
30 September 2024
Summary:
Catalyst Pharmaceuticals TTM revenue is currently $460.48 million, with the most recent change of +$26.01 million (+5.99%) on 30 September 2024. Over the past year, it has increased by +$112.09 million (+32.17%). CPRX TTM revenue is now at all-time high.CPRX TTM Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CPRX Revenue Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +85.9% | +25.3% | +32.2% |
| 3 y3 years | +234.4% | +257.9% | +244.8% |
| 5 y5 years | +10000.0% | +316.5% | +533.5% |
CPRX Revenue High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | at high | +234.4% | at high | +257.9% | at high | +244.8% |
| 5 y | 5 years | at high | >+9999.0% | at high | +341.7% | at high | +533.5% |
| alltime | all time | at high | >+9999.0% | at high | >+9999.0% | at high | >+9999.0% |
Catalyst Pharmaceuticals Revenue History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $128.69 M(+4.9%) | $460.48 M(+6.0%) |
| June 2024 | - | $122.71 M(+24.6%) | $434.48 M(+5.6%) |
| Mar 2024 | - | $98.51 M(-10.9%) | $411.35 M(+3.3%) |
| Dec 2023 | $398.20 M(+85.9%) | $110.57 M(+7.7%) | $398.20 M(+14.3%) |
| Sept 2023 | - | $102.69 M(+3.1%) | $348.39 M(+15.0%) |
| June 2023 | - | $99.58 M(+16.7%) | $302.95 M(+18.1%) |
| Mar 2023 | - | $85.37 M(+40.5%) | $256.48 M(+19.7%) |
| Dec 2022 | $214.20 M(+52.1%) | $60.76 M(+6.1%) | $214.20 M(+11.7%) |
| Sept 2022 | - | $57.24 M(+7.8%) | $191.75 M(+12.5%) |
| June 2022 | - | $53.11 M(+23.3%) | $170.47 M(+10.9%) |
| Mar 2022 | - | $43.09 M(+12.5%) | $153.72 M(+9.1%) |
| Dec 2021 | $140.83 M | $38.31 M(+6.6%) | $140.83 M(+5.5%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2021 | - | $35.95 M(-1.1%) | $133.54 M(+5.2%) |
| June 2021 | - | $36.37 M(+20.4%) | $126.90 M(+5.6%) |
| Mar 2021 | - | $30.20 M(-2.6%) | $120.14 M(+0.9%) |
| Dec 2020 | $119.07 M(+16.4%) | $31.02 M(+5.8%) | $119.07 M(+0.8%) |
| Sept 2020 | - | $29.32 M(-1.0%) | $118.18 M(-1.3%) |
| June 2020 | - | $29.61 M(+1.6%) | $119.76 M(+0.6%) |
| Mar 2020 | - | $29.14 M(-3.3%) | $118.99 M(+16.3%) |
| Dec 2019 | $102.31 M(>+9900.0%) | $30.12 M(-2.5%) | $102.31 M(+40.8%) |
| Sept 2019 | - | $30.90 M(+7.1%) | $72.68 M(+73.9%) |
| June 2019 | - | $28.84 M(+131.7%) | $41.79 M(+222.7%) |
| Mar 2019 | - | $12.45 M(+2389.7%) | $12.95 M(+2489.7%) |
| Dec 2018 | $500.00 K(+2.2%) | $500.00 K(+2.2%) | $500.00 K(+2.2%) |
| Dec 2010 | $489.00 K | $489.00 K | $489.00 K |
FAQ
- What is Catalyst Pharmaceuticals annual revenue?
- What is the all time high annual revenue for Catalyst Pharmaceuticals?
- What is Catalyst Pharmaceuticals annual revenue year-on-year change?
- What is Catalyst Pharmaceuticals quarterly revenue?
- What is the all time high quarterly revenue for Catalyst Pharmaceuticals?
- What is Catalyst Pharmaceuticals quarterly revenue year-on-year change?
- What is Catalyst Pharmaceuticals TTM revenue?
- What is the all time high TTM revenue for Catalyst Pharmaceuticals?
- What is Catalyst Pharmaceuticals TTM revenue year-on-year change?
What is Catalyst Pharmaceuticals annual revenue?
The current annual revenue of CPRX is $398.20 M
What is the all time high annual revenue for Catalyst Pharmaceuticals?
Catalyst Pharmaceuticals all-time high annual revenue is $398.20 M
What is Catalyst Pharmaceuticals annual revenue year-on-year change?
Over the past year, CPRX annual revenue has changed by +$184.00 M (+85.90%)
What is Catalyst Pharmaceuticals quarterly revenue?
The current quarterly revenue of CPRX is $128.69 M
What is the all time high quarterly revenue for Catalyst Pharmaceuticals?
Catalyst Pharmaceuticals all-time high quarterly revenue is $128.69 M
What is Catalyst Pharmaceuticals quarterly revenue year-on-year change?
Over the past year, CPRX quarterly revenue has changed by +$26.01 M (+25.33%)
What is Catalyst Pharmaceuticals TTM revenue?
The current TTM revenue of CPRX is $460.48 M
What is the all time high TTM revenue for Catalyst Pharmaceuticals?
Catalyst Pharmaceuticals all-time high TTM revenue is $460.48 M
What is Catalyst Pharmaceuticals TTM revenue year-on-year change?
Over the past year, CPRX TTM revenue has changed by +$112.09 M (+32.17%)